CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Art Pappas will be a panelist at the Small and Emerging Private Equity Manager Conference, organized by Credit Suisse's Customized Fund Investment Group, in Houston.
News | 04. 19. 2007
